Skip navigation
Browsing by Author Espinoza, D.
Showing results 1 to 3 of 3
| Preview | Issue Date | Title / Name | Author(s) |
| Mar-2021 | High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial | Nair-Shalliker, V.; Smith, D.P.; Gillatt, D.; Gurney, H.; Patel, M.I.; Woo, H.; Rasiah, K.; Symons, J.; Gebski, V.; Espinoza, D.; Frydenberg, M.; Yaxley, J.W.; Gardiner, R.; Kimlin, M.G.; Fenech, M.; Armstrong, B.K.; Rasiah, K.; Awad, N.; Awad, N. | |
| Aug-2021 | MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG) | Siu, H. W. D.; Tebbutt, N.; Chantrill, L.; Karapetis, C.; Steer, C.; Wilson, K.; Espinoza, D.; Bailey, L.; Yip, S.; Cuff, J.; Pavlakis, N.; Thavaneswaran, S.; Briscoe, K.; Srivastav, R.; Shannon, J.; Segelov, E.; Tie, J.; Caird, S.; Francesconi, A.; Price, T.; Wuttke, M.; Ladwa, R.; Sjoquist, K.; Burge, M.; Briscoe, Karen | |
| Nov-2015 | A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial | Davidson, A; Veillard, A-S; Tognela, A.; Chan, M. M. K.; Hughes, B. G. M.; Boyer, M.; Briscoe, K.; Begbie, S.; Abdi, E.; Crombie, C.; Long, J.; Boyce, A.; Lewis, C. R.; Varma, S.; Broad, A.; Muljadi, M.; Chinchen, S.; Espinoza, D.; Coskinas, X.; Pavlakis, N.; Millward, M.; Stockler, M. R.; Australasian Lung cancer Trials Group ALTG; Briscoe, Karen; Begbie, Stephen | |
